Effect of an Arabinogalactan Product

Clinical Trial ID NCT04005924

Rank	Title	Journal	Year	PubWeight™‹?›
1	Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.	Eur J Clin Nutr	2006	1.03
2	Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects.	Am J Clin Nutr	2000	0.97
3	Effects of concentrated arabinoxylan and β-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study.	Eur J Clin Nutr	2013	0.90
4	Arabinoxylans and arabinogalactans: a comprehensive treatise.	Crit Rev Food Sci Nutr	2011	0.87
5	Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects.	J Am Coll Nutr	2001	0.87
6	Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance.	Horm Metab Res	2006	0.84
7	Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.	Eur J Clin Nutr	2014	0.77
8	Does larch arabinogalactan enhance immune function? A review of mechanistic and clinical trials.	Nutr Metab (Lond)	2016	0.75